Soybean glucanases, compounds which encode therefor and related methods by Jin, Wei et al.
Iowa State University Patents Iowa State University Research Foundation, Inc.
9-14-1999
Soybean glucanases, compounds which encode
therefor and related methods
Wei Jin
Iowa State University
Harry T. Horner
Iowa State University, hth@iastate.edu
Reid G. Palmer
Iowa State University
Randy C. Shoemaker
Iowa State University
Follow this and additional works at: http://lib.dr.iastate.edu/patents
Part of the Other Plant Sciences Commons, Plant Biology Commons, and the Plant Breeding
and Genetics Commons
This Patent is brought to you for free and open access by the Iowa State University Research Foundation, Inc. at Iowa State University Digital
Repository. It has been accepted for inclusion in Iowa State University Patents by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Jin, Wei; Horner, Harry T.; Palmer, Reid G.; and Shoemaker, Randy C., "Soybean glucanases, compounds which encode therefor and
related methods" (1999). Iowa State University Patents. 323.
http://lib.dr.iastate.edu/patents/323
Soybean glucanases, compounds which encode therefor and related
methods
Abstract
The present invention provides 12 different sequences for soybean β-1,3-glucanases and the proteins for
which they encode. Also provided are methods for the utilization of knockout mutants of the sequences
which are useful for engineering genic male-sterile plants. Other methods and materials related to these
sequences are also provided.
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SOYBEAN GLUCANASES, COMPOUNDS 
WHICH ENCODE THEREFOR AND 
RELATED METHODS 
BACKGROUND OF THE INVENTION 
The present inventors recently characterized a genic male 
sterile mutant of soybean: 83(6) Am. J. Bot. 42, abstract 
121(1996); Jin et al., 10 Sex Plant Reprod. 13 (1997). 
Microscopic analysis of the mutant shoWed the callose 
encasement of the microspores Was retained at an inappro 
priate developmental stage. The persistent callose encase 
ment resulted in no release, and subsequent degeneration of 
the microspores. Other results in these publications shoWed 
that callase, the enZyme Which is responsible for digestion of 
the callose Wall, Was inactive. The reason for the inactivity 
Was not elucidated at that time. 
Other publications by the present inventors identi?ed the 
callase as a [3-1,3-glucanase. Abstract P14, Genetics Society 
of Canada (June 1997); 114(3) Plant Physiology 172, 
abstract 842 (June 1997); 84(6) Am. J. Bot. 63, abstract 182 
(June 1997). 
Soybean [3-1,3-glucanases have been cloned in the past. 
For example, U.S. Pat. No. 5,477,001 disclosed cloned 
[3-1,3- glucanases from soybean. The gene products are 
implicated in disease resistance. No disclosure of the 
involvement of [3-1,3- glucanases as a callase is described in 
the patent. Non-soybean glucanases, such as those described 
in U.S. Pat. No. 5,554,743 describe [3-1,3-glucanases 
involved in cell Wall polysaccharide degradation. 
A search of the National Institutes of Health BLAST 
database disclosed a line of soybean “Glycine max cv. 
Century 84” With cloned [3-1,3-glucanases. None of the 
sequences found Were identical to the presently-claimed 
sequences. The folloWing is a table of the results of the 
search. 
SEQ 
ID 
NO CLOSEST HOMOLOGY REFERENCE 
1 85% (soybean glucanase) U.S. Pat. No. 5477001, Seq 8; 
same as WO9413790, Seq 15 
none available 
26 Crop Science 199 (1986) 
U.S. Pat. No. 5477001, Seq 8; 
same as WO9413790, Seq 15 
26 Crop Science 199 (1986) 
26 Crop Science 199 (1986) 
U.S. Pat. No. 5614395, Seq 13; 
same as WO9413790, Seq 15 
U.S. Pat. No. 5477001, Seq Id 8; 
same as WO9413790, Seq 15 
26 Crop Science 199 (1986) 
2 98% (soybean endoglucanase) 
3 91% (Century 84) 
4 97% (soybean glucanase) 
5 76% (Century 84) 
6 91% (Century 84) 
7 54% (unknown) 
8 85% (soybean glucanase) 
9 75% (Century 84) 
10 97% (Century 84) 26 Crop Science 199 (1986) 
11 76% (Century 84) 26 Crop Science 199 (1986) 
12 96% (soybean glucanase) U.S. Pat. No. 5477001, Seq Id 8; 
same as WO9413790, Seq 15 
The U.S. Pat. No. 5,477,001 does not disclose or suggest 
the present invention, because the sequences described 
herein are not disclosed. Moreover, the emphasis in the U.S. 
Pat. No. 5,477,001 is the use of a particular soybean gluca 
nase to resist plant diseases. In certain aspects of the present 
invention, the focus is on the elimination of active soybean 
glucanases; the U.S. Pat. No. 5,477,001 therefore teaches 
aWay from those aspects of the present invention. 
Century 84 is a line of soybean Which Was released jointly 
by the Ohio Agricultural Research and Development Center, 
The Ohio State University and the USDA Which contained 
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2 
over-expressed glucanase for the purpose of disease resis 
tance. Registration Number 188,26 Crop Science 199 
(1989). 
Citation of the above documents is not intended as an 
admission that any of the foregoing is pertinent prior art. For 
example, in some instances above, the publication Was less 
than one year before the ?ling date of this patent application. 
All statements as to the date or representation as to the 
contents of these documents is based on subjective charac 
teriZation of information available to the applicant at the 
time of ?ling, and does not constitute an admission as to the 
accuracy of the dates or contents of these documents. 
SUMMARY OF THE INVENTION 
It is therefore an object of the present invention to provide 
sequences useful to engineer male-sterile soybean lines. 
It is a further object to provide methods to engineer 
male-sterile soybean lines. 
It is yet another object to provide male-sterile soybean 
seeds. 
It is yet another object to provide male-sterile soybean 
plants. 
In all of the above embodiments, it is an object to provide 
seed mixes With male-sterile and female-fertile seeds. 
It is also an object of the invention to provide materials 
such as vectors for genetic engineering male-sterile soybean 
lines. 
It is an additional object to provide a method to improve 
seed germination using the materials herein disclosed. 
Lastly, it is therefore an object of the present invention to 
provide sequences useful to engineer disease-resistant soy 
bean lines. 
DEFINITIONS 
For the purposes of the present application, the folloWing 
terms have the folloWing meanings. All other terms have the 
meaning as generally recogniZed in the art. 
“Knockout construct” means a DNA sequence Which has 
been altered via any knoWn means, for example, deletion, 
insertion, point mutation or rearrangement, so as to elimi 
nate the function of the naturally-occurring [3-1,3 glucanase 
of the pod and ?oWer bud of a soybean plant gene product, 
but not so as to alter the ability of the DNA sequence to 
recombine With the naturally-occurring sequence. 
“Knockout mutants” are cells, embryos or plants in Which 
a naturally-occurring [3-1,3-glucanase gene has been 
replaced through genetic engineering With a knockout 
construct, so as to result in a male-sterile phenotype. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention provides tWelve different sequences 
for soybean [3-1,3 glucanases and the proteins for Which they 
encode. The DNA sequences are as folloWs: 
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SEQ 
ID 
NO SEQUENCE 
10 
ll 
12 
AGTACATTGCAGTCGGTAACGAATTCTTTAGCAGGGTCTGTACTTCCAGCACTTGAAAACATTCAGAACGCAACTTCTGCCGCCAAT 
TTACAAGGCCAAATGAAGGTGTCAACAGCAATAGACACCACTTTACTTGGCAACTCTTACCCACCAAAAGATGGCGTTTTCAGCAGT 
AGTGCAAGTTCATACATAAGACCAATTGTAAACTTTTGAGCTAGAAATGGAGCTCCACTTCTCGCAAACGTGTACCCTTACTTCGCC 
TATGTTAACGACCAACAAAGCATTAGTCTCGACTATGCCTTGTTTACTGAACATGGTAACAACGAGGCTGGGTACCAAAACCTGTTT 
GATGCATTGTTGGATTCTCTATACGCTGCTCTTGAGAAAGTAGGGGCACCCAATGTGACGGTTGTTGTGTCTGAAACGGGCTGGCCG 
CGGGATCCGGTGTTTGTTATGGAGTGATTGGTGATAATCTACCATCAAGGCAAGAAGTTGTGGACTTATATAAAACAAATGGCATTG 
GTAGAATGCGTATATACTACCCAGATGAAGAAGCACTCCAAGCCCTTAGAGGTTCAGGCATTGAGTTGATTATGGACGTGGCTAAG 
GAAACCCTTCAATCATTGACAGACTCCAATGCTGCTACAGATTGGGTCAATAAATATGTTACACCTTACTCGCAAGACGTCAATTT 
CAAGTACATCGCTGTTGGAAATGAAATTCATCCCAATACCAATGAGGCACAATATATTCTATCTGCCATGACCAACATTCAGAATG 
CAATTTCATCAGCAAATTTACAAATTAAGGTGTCAACAGCTATAGACTCTACTTTGATTACTAACTCTTACCCTCCCAATGATGGC 
GTTTTCACTAGCGATGCGGAGCCATACATAAAACCCATAATCAACTTCCTAGTGAGCAATGGGGCCCCAATTCTTGCCAACGTGTA 
CCCTTACTTTGCTTATGCAAATGATCAAAGCATTCCTCTTGCCTATGCTCTTTTTACCCAACAAGGAAACAACGACGTTGGGTACC 
AAAACCTCTTTGATGCTATGTTGGATTCAATATATGCTGCTTTGGAGAAAGTGGGAGCGTCCAATTTGCAGATAGTGGTTTCTGAG 
TGAGGATGGCCGAATTCCG 
CGGGATCCGGTGTGTGTTACGGAGGAAATGGAAACAATCTACCAACAAAGCAAGCAGTGGTGGATCTTTACAAATCAAACAGAATA 
GGCAAAATCCGTTTATACTATCCAGACGAAGGAGTCCTTCAAGCCCTCAGAGGTTCAAACATAGAGGTGATCCTCGGTGTCCCTAA 
TGACCAACTTCATTCTCTCACCAACGCTGGAGCTGCCACAAATTGGGTCAACAAGTACGTGAAAGCATACTCACAAAACGTGAAAT 
TCAAGTACATTGCAGTTGGTAACGAAATTCACCCTGGTGACTCTTTAGCAGGGTCTGTACTTCCAGCACTTGAAAACATTCAGAAA 
GCAATTTCTGCCGCCAATTTACAAGGCCAAATGAAGGTGTCAACAGCAATAGACACCACTTTACTTGGCAACTCTTACCCACCAAA 
AGATGGCGTTTTCAGCAGTAGTGCAAGTTCATACATAAGACCAATTGTAAACTTTTTAGCAAGAAATGGAGCCCCACTTCTCGCAA 
ACGTGTACCCTTACTTCGCCTATGTTAACAACCAACAAAGCATTGGTCTTGACTATGCCTTGTTTACTAAACATGGTAACAACGAG 
GTTGGGTACCAAAACCTGTTTGATGCATTGCTGGATTCCCTATACGCTGCTCTTGAGAAAGTAGGGGCACCAAATGTGAAGGTTGT 
TGTGTCTGAGTGCGGATGGCCGAATTCCG 
CGGAATTCGGCCATCCACTTTCGGATACAACAACCTCCACATAACCAATCTTAGTGTTATCAATGGCTGCATGTACTGAATCCAACA 
TAGCATCAAACAAATTTTGGTACCCATATTGACCATCCCATACCACAACATTTGGTGCTGTGAAAAGAGCATAGGGAAGTGATATGT 
CACGGGGGTTACCAGTGTAACTAAAATAAGGGTACACATTGACTAGTAATGGTGCATTTGCATATACCAAGTACCCAATTATGGGAT 
CTATGTATGATCTCACATCACCCCTGAAGGAACCTTGCGATGGAGGGAAAGATTTCCTATTAGGGTCATGTCAATATATGTTGAAAC 
CTTGATTTGATCNTGAAGGCCTTGAGCTCTTATTGCTTGGTATACATTTTGGATGGCAGGTAGAACATATTGGGCTACCGAAGAAGA 
GCCTCCAACGGGACTCACTTCATTTCCAACTGCCACGTACTTGATTTTGACACTAGGCCAGAAGTTCTACACGTTTTTTTGCACCCA 
TTGACGAGAAGTGTCAGGATTGGTGGCAAGGCCTTGAAGGTCAGAGTTTGGCACCCCAAGAATGAGTTCAATGCCAGAATTTCTAAG 
TGCTTCTAGAGCAGCTTGATTAGGATCATAGAGTCTCATTCTCTTTATGTTATTTGATCTATAAAGACCTATAACATCGTTTGCTGA 
CGGTAGATTGTTGCCCAGCATGCCGTA 
Vectors Which comprise the above sequences are Within 
the scope of the present invention, as are plants transformed 
With the above sequences. Vectors may be obtained from 
various commercial sources, including Clontech 
Laboratories, Inc. (Palo Alto, Calif), Stratagene (La Jolla, 
Calif), Invitrogen (Carlsbad, Calif), NeW England Biolabs 
(Beverly, Me.) and Promega (Madison, Wis.). 
Preferred vectors are those Which are capable of transfer 
ring the sequences disclosed herein into plant cells or plant 
parts. 
60 
65 
Methods to inhibit plant diseases, including use of a 
compound herein disclosed, according to the procedures 
described in Us. Pat. No. 5,477,001, Which patent is 
expressly incorporated by reference, are also part of the 
present invention. 
Moreover, the most commercially signi?cant use of the 
present invention is in the construction of “knockout 
mutants” using the above sequences, or knoWn soybean 
sequences, for design and construction of male-sterile 
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mutants. In other Words, the present invention is informative 
to those skilled in the art as to their usefulness in making the 
naturally-occuring gene inactive. For example, the above 
sequences can be mutated by any means, i.e., deletion, 
insertion, point mutation, rearrangement, etc, so long as the 
mutated version retains the ability to recombine. The 
mutated version of the gene is then introduced into cells of 
a preferred soybean line via routine methods (ie. biolistic 
processes, lambda phage transformation, etc.). Male-sterile 
mutants of the preferred line Would then be selected and 
propagated. These “knockout” mutant embryos, seeds and 
plants are Within the scope of the present invention, as are 
the knockout constructs, ie. sequences and vectors. 
In particular, sequences near the active sit of enZyme 
function, and the sit itself, Would be preferred targets. For 
example, the codons for amino acid residues 240 through 
250 Would be a preferred knockout, but most preferred 
Would be a construct Wherein the codons encoding 245 
through 248 Were deleted. 
For example, the folloWing seeds, embryos or plants 
transformed With knockout constructs are considered Within 
the present invention: soybean, maiZe, beet, tobacco, Wheat, 
barley, poppy, rape, sun?ower, alfalfa, sorghum, rose, 
carnation, gerbera, carrot, tomato, lettuce, chicory, pepper, 
melon and cabbage. Particularly preferred are: soybean, 
tobacco and maiZe. HoWever, any seed, embryo or plant 
Which gives rise to a plant Which has a callose encasement 
of the microspores is Within the scope of the present inven 
tion. Of course, those in the art recogniZe that any seed, 
embryo or plant transformed With knockout constructs 
Which are useful for producing plants for biomass are Within 
the scope of the present invention. 
Transformation of cells With the compounds of the present 
invention can be accomplished according to knoWn proce 
dures. For example, infective, vector-containing bacterial 
strains (such as Agrobacterium rhizogenes and Agrobacte 
rium tumefaciens) may be used for transformation. 
Zambryski, 43 Ann. Rev. Pl. Physiol. Pl. Mol. Biol 465 
(1992). The folloWing procedures are also Well-knoWn: 
Pollen-tube transformation [Zhon-xun et al., 6 Plant Molec. 
Bio. 165(1988)]; direct transformation of germinating seeds 
[Troepfer et al., 1 Plant Cell 133 (1989)]; polyethylene 
glycol or electroporation tranformation [Christou et al., 84 
Proc. Nat. Acad. Sci. 3662 (1987)]; and biolistic processes 
[Yang & Cristou, Particle Bombardment Technology for 
Gene Transfer (1994)]. The transformed cells are also Within 
the scope of the present invention. 
The transformed cells may be induced to form trans 
formed plants via organogenesis or embryogenesis, accord 
ing to the procedures of Dixon Plant Cell Culture: A 
PracticalApproach (IRL Press, Oxford 1987). 
Therefore, also provided are methods for constructing 
sequences With the ability to knockout the above sequences, 
comprising one of the folloWing techniques: inserting a 
foreign piece of DNA into one of the disclosed sequences; 
deleting a piece of DNA from one of the disclosed 
sequences; or creating a mutation such that the [3-1,3 
glucanase activity is eliminated. 
Also provided are antisense constructs and methods to 
inhibit mRNA transcripts of the disclosed sequences, so as 
to either eliminate or reduce the amount of gene product. 
The procedures for antisense inhibition for mRNA are 
described in US. Pat. No. 5,554,743, Which patent is 
expressly incorporated by reference into this application. 
Also provided in the present invention are methods to 
improve seed germination, comprising expressing or over 
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10 
expressing the [3-1,3-glucanase(s) described herein, and 
using the glucanases to digest the callose Wall of mature 
seeds [i.e., Cucumis Speices; Yim and Bradford, 114(3) 
Plant Physiology 289, abstract 1506 (1997)]. The seeds can 
then be germinated according to traditional methods. Over 
expression can be as skill of the art, in particular, according 
to the procedures described in US. Pat. No. 5,477,001. 
Lastly, the present invention includes methods to alter the 
naturally-occurring expression pattern of the [3-1,3 
glucanase genes so as to either delay or prematurely digest 
the callose Wall. In other Words, in a none-male-sterile plant, 
a glucanase gene is expressed (and the callose encasement 
digested) at a critical point in microsporogenesis called “the 
late tetrad stage.” If the genes Which digest the callose 
encasement are not active at the late tetrad stage, or if they 
are active before the late tetrad stage, the potential for pollen 
formation is lost. In the instance Where the [3-1,3-glucanase 
genes are expressed earlier than the late tetrad stage, the 
microspores Would be too immature. In the case Where the 
[3-1,3-glucanase genes are expressed later than the late tetrad 
stage, the microspores Would be arrested in development. 
Since disease resistance is one characteristic conferred to 
a plant by the expression of [3-1,3-glucanase, an ideal 
method Would be to activate the sequences disclosed herein 
(or other glucanase sequences), and have the gene consti 
tutively expressed thereafter. HoWever, another embodiment 
of this invention is to alter the expression pattern so that the 
[3-1,3-glucanase genes turn on later than the late tetrad stage. 
Constitutive expression thereafter may also be engineered. A 
preferred method in this regard is alteration of the regulatory 
regions of SEQ ID NO 7 so as to affect the expression of a 
[3-1,3-glucanase either earlier or later than the late tetrad 
stage. 
In particular, in order to practice the altered expression 
pattern aspect of the present invention, one Would have to 
construct a vector Which provided for either an early or late 
promoter in conjunction With the present sequences. For 
instance, the folloWing promoters Would be useful in early 
expression of the present sequences: 
Ogs4B (Tsuchiya et al., 36 Plant Cell Physiology 487 
(1994) 
TA29 (KoltunoW et al., 2 Plant Cell 1201 (1990) 
A3 & A9 (Paul et al., 19 Plant Molecular Biology 611 
(1992) 
In order to then constitutively express the sequences 
described above, the construct optionally contains, for 
example, a 35S promoter. 
Therefore, the present invention provides methods to 
express the [3-1,3-glucanase genes described herein in a 
plant Which has a callose encasement of microspores, at a 
time other than the late tetrad stage, comprising groWing a 
plant transformed With a vector Which alloWs expression at 
a time other than the late tetrad stage of a sequence selected 
from the group consisting of: SEQ ID NO 1; SEQ ID NO 2; 
SEQ ID NO 3; SEQ ID NO 4; SEQ ID NO 5; SEQ ID NO 
6; SEQ ID NO 7; SEQ ID NO 8; SEQ ID NO 9; SEQ ID NO 
10; SEQ ID NO 11 and SEQ ID NO 12. 
A method as above, Wherein the [3-1,3-glucanase genes 
are then consititutively expressed is preferred. 
Transformation of plants With these sequences Would be 
according to knoWn procedures as described above. Plants 
can be groWn according to knoWn procedures. 
In addition, there are provided male-sterile soybean seeds, 
embryos and plants comprising a knockout construct of 
soybean [3-1,3-glucanase gene, in particular, soybean seeds, 
embryos and plants Wherein the soybean [3-1,3-glucanase 
gene knocked out is SEQ ID NO 7 are provided. 
5,952,548 
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EXAMPLES 
EXAMPLE 1 
NUCLEIC ACID MANIPULATIONS 
Plant tissues for nucleic acid isolation Were collected from 
the soybean cultivar Minsoy (PI 27890) grown in the 
greenhouse or groWth chamber. Material for RNA extraction 
Was immediately froZen in liquid nitrogen and stored at —80° 
C. until used. Soybean genomic DNA Was extracted from 
freeZe-dried young leaves, folloWing the protocol by Keim 
et al., 15 Soybean Genet. Newsl. 150 (1988). Total DNA(10 
ng) was digested and subjected to Southern blotting as 
described by Sambrook et al., Molecular Cloning: A Labo 
ratory Manual (Cold Spring Harbor 1989). Total RNA Was 
extracted using guanidinum isothiocyanate extraction 
according to ChamcZynski & Sacchi, 162 Anal. Biochem. 
156 (1987), electrophoresed on formaldehyde-agarose gels, 
and blotted onto Zeta Probe Nylon membrane (Biorad) as 
described by Sambrook et al. (above). Filters Were prehy 
bridiZed 3 house at 65° C. in 5x SSC, 2% SDS, 5>< 
Denhardt’s solution, 0.1 mg/ml herring sperm DNA. 
Hybridization Was carried out overnight at 65° C. with 2x 
SSC+0.4% SDS and 1x SSC+0.4% SDS at 60° C. before 
exposure for autoradiography. 
EXAMPLE 2 
PCR AMPLIFICATION, CLONING AND 
SEQUENCE ANALYSIS 
Coding region segments encoding [3-1,3-glucanase Were 
ampli?ed from soybean genomic DNA and ?oWer bud 
cDNA using primers that matched conserved sequences 
Within the [3-1,3-glucanases of other species as described by 
Simmons, 13 Critical Rev. Plant Sci. 325 (1994). To obtain 
cDNA, mRNA Was prepared from ?oWer buds, the mRNA 
Was incubated With 5 nM random hexamers, 1 mM each of 
dATP, dCTP, dGTP and dTTP and 2 U/nl RNase inhibitor 
(Promega) in 10 mM Tris-HCl (pH 8.3), 50 M KCl, 2.5 M 
MgCl2 for 30 min at 37° C., and then for a further 45 minutes 
at 37° C. folloWing the addition of 20 U/nl superscript 
reverse transcriptase (BRL). After heating at 65° C. for 3 
minutes, cDNA prepared from 0.1 pig of mRNA Was used in 
the PCR experiments. Each 25 pl PCR contained 60 ng of 
soybean genomic DNA or 20 ng of ?oWer cDNA, 10 mM 
Tris-HCl (pH 8.3), 50 mM KCl, 3 mM MgCl2, 200 nM (each 
dATP, dCTP, dGTP, and dTTP, 2.5 U of Taq polymerase 
(BRL Life Technology), and 2 nM (each) PCR primer. PCR 
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ampli?cations Were performed according to the follWing 
schedule: 96° C. for 1 minute, 44° C. for 1 minute, 72° C. 
for 1 minute for 4 cycles, folloWed by 94° C. for 1 minute, 
55° C. for 1 minute, 72° C. for 1 minute for 30 cycles. The 
5‘ primer Was 5‘-CGCGGNGTNTGYTAYGG-3‘; the 3‘ 
primer Was 5 ‘-CGCGGCCAN CCNSWYTC-3‘ (Where N=A, 
C,G,T; R=A,G; Y=C,T; S=C,G and W=A,T). The regions 
used correspond to amino acids 37—41 and 276—282 accord 
ing to Simmons (see above). An aliquot of each PCR product 
Was analyZed by agarose gel electrophoresis. A 700 bp 
fragment Was cut from the gel and subjected to another 
round of PCR using identical conditions. Aliquots of these 
PCR products Were digested With restriction enZymes rec 
ognixing 4 bp sites and the digestion products Were com 
pared With undigested DNA on agarose gels. The PCR 
products Were cloned into the pGEM-T vector (Promega) 
and about 280 clones Were tested by dot blot analysis 
(Sambrook et al, see above) to determine if they cross 
hybridiZed With one another. 
Cones Were sequenced using Applied Biosystems Model 
337 PRISM automated sequencer. DNA sequence analysis 
Was carried out With the DNAsis (Hitachi), GCG (University 
of Wisconsin Genetics Computer Group, Madison) sequence 
analysis packages. Alignment of sequences Was done using 
CLUSTAL W according to Thompson et al., 22 Nucl. Acids 
Res. 4673 (1994). 
EXAMPLE 3 
EXPRESSION PATTERNS OF GLUCANASES 
In order to study gene-speci?c glucanase expression 
patters, the presence of mRNAs corresponding to each 
sequence disclosed herein Was analyZed by RNA blot analy 
ses using the gene-speci?c probes. The expression levels of 
all classes Were quite loW in young leaves. SEQ ID NOs 2, 
4, 7 and 12 Were highly expressed in young roots and 
hypocotyls. SEQ ID NO 7 Was also expressed in the pod and 
?oWer bud. The mRNA transcripts of all [3-1,3-glucanase 
genes Were shoWn to be about 1.2 kb. mRNA from SEQ ID 
Nos 1, 3, 8 and 9 Was undetectable, suggesting that these 
genes are either unexpressed, expressed at loW level, or 
inducible. 
Although the present invention has been fully described 
herein, it is to be noted that various changes and modi?ca 
tions are apparent to those skilled in the art. Such changes 
and modi?cations are to be understood as included Within 
the scope of the present invention as de?ned by the 
appended claims. 
SEQUENCE LISTING 
(1) GENERAL INFORMATION: 
(iii) NUMBER OF SEQUENCES: l2 
(2) INFORMATION FOR SEQ ID NO:1 : 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 741 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
5,952,548 
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-continued 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: 
CGGGATCCGG GGTGTGTTAC GGCATGATGG GCGACAATCT ACCACCGGCA AATGAAGTTG 60 
TAAGTCTTTA CAAATCCAAC GACATAATGA GAATGAGAAT CTATAATCCT GATCAAGCTG 120 
CTTTACAAGC ACTGGGAAAT TCGGGCATTG AGCTTATTCT TGGGGTGCTC CACCAAGACC 180 
TTCAAGGCCT TGCCACCAAT GCTAGCACTG CTCAACAATG GGTGCAAAGT AACGTGTTGA 240 
ACTTTTGGCC TAGTGTCAAA ATCAAGCACG TGGTAGTTGG CAACGAAATC AATCCTGTGG 300 
GAAGCTCTTC TGAGTTTGCC CAATATGTTC TACCTGCAAT CCAAAACATA TACCAAGCTA 360 
TAAGAGCTCA AGGCCTTCAA GATCTAATCA AGGTTACAAC AGCTATTGAC ATGACCCTGT 420 
TAGGAAACTC CTACCCCCCA TCACAAAGCT ACTTCAGGAC TGATGTGAGA TCATACTTAG 480 
ACCCCATAAT TGGGTACTTG GTATATGCAA ATGCACCTTT ACTAGCCAAT GTGTTGCCTT 540 
ATTTTAGTTA CTCCAATAAC CCGATTGACA TATCACTTTC CTATGCTCTT TTTAACTCAA 600 
CAAATGTTGT GGTTTGGGAT GGTCAATATG GGTACCAAAA TTTGTTTGAT GCTATGTTGG 660 
ATGCGGTGCA TGTTGCAATT GATAACACAG GGATTGGTTA TGTGGAGGTT GTTGTATCCG 720 
AGAGAGGTTG GCCGAATTCC G 741 
(2) INFORMATION FOR SEQ ID NO:2: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 735 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: 
CGGGATCCGG CGTGTGTTAT GGAAGACTTG GCAACAACTT ACCAACCCCT CAAGAAGTTG 60 
TGGCCCTCTA CAATCAAGCC AACATTCGCA GGATGCGAAT CTACGGTCCA AGCCCAGAAG 120 
TCCTCGAAGC ACTAAGAGGT TCCAACATTG AGCTTTTGCT AGACATTCCA AATGACAACC 180 
TCAGAAACCT AGCATCTAGC CAAGACAATG CAAACAAATG GGTGCAAGAC AACATCAAAA 240 
ACTATGCCAA CAATGTCAGA TTCAGATACG TTTCAGTGGG AAATGAAGTG AAACCCGAAC 300 
ACTCATTTGC ACAATTTCTA GTGCCTGCAT TGGAAAACAT TCAGAGGGCC ATTTCTAATG 360 
CTGGCCTTGG AAACCAAGTA AAAGTTTCCA CTGCCATTGA TACTGGTGCC TTGGCAGAAT 420 
CATTCCCACC ATCAAAGGGT TCCTTCAAAT CTGATTATAG AGGAGCATAT CTTGATGGTG 480 
TCATCAGATT TCTAGTGAAC AATAATGCCC CATTAATGGT TAATGTGTAC TCTTACTTCG 540 
CTTACACTGC AAACCCTAAG GACATTAGTC TTGACTATGC ACTTTTTAGG TCTCCTTCGG 600 
TGGTAGTGCA AGATGGTTCA CTTGGTTACC GTAACCTCTT TGATGCTTCG GTTGATGCTG 660 
TTTATGCTGC ATTGGAGAAA GCAGGAGGAG GGTCATTGAA CATAGTTGTG TCTGAGTGAG 720 
GATGGCCGAA TTCCG 735 
(2) INFORMATION FOR SEQ ID NO:3: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 717 base pairs 
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(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: 
CGGGATCCGG AGTTTGCTAT GGAGTACTCG GTAATAATCT ACCATCAAGG CAAGAAGTTG 60 
TGGACTTGTA TAAAACAAAT GGGATAGGTA GAATGCGTAT ATACTATCCA GATGAAGAAG 120 
CGCTCCAAGC CCTTAGAGGT TCAGGCATTG AGTTGATTAT GGACGTGGCT AAGGAAACCC 180 
TTCAATCAAT GACAGACCCC AATGCTGCTA CAGATTGGGT CAATAAGTAT GTTACAGCCT 240 
ACTCGCAAGA CGTCAATTTC AAGTACATCG CTGTTGGAAA TGAAATTCAC CCCAATACCA 300 
ATGAGGCACA GTACATTCTA TCTGCCATGA CCAACATTCA GAATGCAATT TCATCAGCCA 360 
ATTTACAAAT CAAGGTGTCA ACAGCAATAG ACTCTACTTT CATTGCTCCG CCCTCCTATC 420 
CACCCAATGA TGCTGTTTTC ACTAGCGATG CAGAGCCATA TGTAAAACCC ATAATAGACT 480 
TCCTAGTGAG AAATGAGGCG CCACTTCTTG CCAATGTGTA CCCTTACTTT GCTTATGCGA 540 
ATGATCAACA AAACAGTATT CCTCTTGCCT ATGCTCTTTT TACCCAACAA GGAAACAACG 600 
ACGCTGGGTA CCAAAACCTC TTCGATGCTA TGTTGGATTC AATATACGCT GCAGTGGAGA 660 
AAGTGGGAGC ATCCAATTTG CAGATAGTGG TTTCTGAATC TGGTTGGCCG AATTCCG 717 
(2) INFORMATION FOR SEQ ID NO: 4: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 745 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: 
CCTAAACTAC GTGCGGGATC CGGGGTATGT TATGGCATGC TGGGCAACAA TCTACCATCA 60 
GCAAACGAAG TTATAGGTCT TTATAGATCA AATAACATAA GGAGAATGAG ACTCTATGAT 120 
CCTAATCAAG CTGCTCTAGA AGCACTTAGA AATTCTGGCA TTGAACTCAT TCTTGGGGTG 180 
CCAAACTCTG ACCTTCAAGG CCTTGCCACC AATCCTGACA CTTCTCGTCA ATGGGTGCAA 240 
AAAAACGTGT TGAACTTTTG GCCTAGTGTC AAAATCAAGT ACGTGGCAGT TGGAAATGAA 300 
CTGAGTCCCG TTGGACGCTC TTCTTCGGTA GCCCAATATG TTCTACCTGC CATCCAAAAT 360 
GTATACCAAG CAATAAGAGC TCAAGGCCTT CATGATCAAA TCAAGGTTTC AACATCTATT 420 
GACATGACCC TAATAGGAAA CTCTTTCCCT CCACCGCAAG GTTCCTTCAG GGGTGATGTG 480 
TGATCATACC TAGATCCCAT AATTGGGTAC TTGGTATATG CAAATGCACC ATTACTAGTC 540 
AATGTGTACC CTTATTTTAG TTACACTGGT AACCCCCGTG ACATATCACT TCCCTATGCT 600 
CTTTTCACAG CACCAAATGT TGTGGTATGG GATGGTCAAT ATGGGTACCA AAATTTGTTT 660 
GATGCTATGT TGGATTCAGT ACATGCAGCC ATTGATAACA CTAAGATTGG TTATGTGGAG 720 
GTTGTTGTAT CCGAAAGCGG ATGGA 745 
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(2) INFORMATION FOR SEQ ID NO:5: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 718 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: 
CGGGCATCCG GTGTCTGTTA CGGAGGAAAT GGAAACAATC TACCAACAAA GCAAGCAGTG 60 
GTGGATCTTT ACAAATCAAA CAGAATAGGC AAAATCCGTT TATACTATCC AGACGAAGGA 120 
GTCCTTCAAG CCCTCAGAGG TTCAAACATA GAGGTGATCC TCGGTGTCCC TAATGACCAA 180 
CTTCAATCTC TCACCAACGC TGGAGCTGCC ACAAATTGGG TCAACAAGTA CGTGAAAGCA 240 
TACTCACAAA ACGTGAAATT CAAGTACATT GCAGTTGGTA ACGAAATTCA CCCTGGTGAC 300 
TCTTTAGCAG GGTCTGTACT TCCAGCACTT GAAACCATTC AGAAAGCAAT TTCTGCCGCC 360 
AATTTACAAG GCCAAATGAA GGTGTCAACA GCAATAGACA CCACTTTACT TGGCAACTCT 420 
TACCCACCAA AAGATGGCGT TTTCAGCAGT AGTGCAAGTT CATACATAAG ACCAATTGTA 480 
AACTTTTTAG CAAGAAATGG AGCCCCACTT CTCGCAAACG TGTACCCTTA CTTCGCCTAT 540 
GTTAACAACC AACAAAGCAC TGGTCTTGAC TATGCCTTGT TTACTAAACA TGGTAACAAC 600 
GAGGTTGGGT ACCAAAACCT GTTTGATGCA TTGTTGGATT CTCTATACGC TGCTCTTGAG 660 
AAAGTAGGGG CACCAAATGT GAAGGTTGTT GTGTCTGAAA GAGGTTGGCC GAATTCCG 718 
(2) INFORMATION FOR SEQ ID NO: 6: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 719 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: 
CGGGATCCGG GAGTATGTTA CGGGAGTACT CGGTAATAAT CTACCATCAA GGCAAGAAGT 60 
TGTGGACTTG TATAAAACAA ATGGGATAGG TAGAATGCGT ATATACTATC CAGATGAAGA 120 
AGCACTCCAA GCCCTTAGAG GTTCAGGCAT TGAGTTGATT ATGGACGTGG CTAAGGAAAC 180 
CCTTCAGTCA ATGACAGACC CCAATGCTGC TACAGATTGG GTCAATAAGT ATGTTACAGC 240 
CTACTCGCAA GACGTCAATT TCAAGTACAT CGCTGTTGGA AATGAAATTC ACCCCAATAC 300 
CAATGAGGCA CAGTACATTC TATCTGCCAT GACCAACATT CAGAATGCAA TTTCATCAGC 360 
CAATTTACAA ATCAAGGTGT CAACAGCAAT AGACTCTACT TTCATTGCTC CGCCCTCCTA 420 
TCCACCCAAT GATGCTGTTT TCACTAGCGA TGCAGAGCCA TATGTAAAAC CCATAATAGA 480 
CTTCCTAGTG AGAAATGAGG CGCCACTTCT TGCCAATGTG TACCCTTACT TTGCTTATGC 540 
GAATGATCAA CAAAACAGTA TTCCTCTTGC CTATGCTCTT TATACCCAAC AAGGAAACAA 600 
CGACGCTGGG TACCAAAACC TCTTCGATGC TATGTTGGAT TCAATATACG CTGCAGTGGA 660 
GAAAGTGGGA GCATCCCAAT TTGCAGATAG TGGTTTCTGA AAGAGATGGC CGAATTCCG 719 
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(2) INFORMATION FOR SEQ ID NO: 7: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 737 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: 
CGGGATCCGA GTTTGTTATG GAAGAAGTGC TGATGACCTC CCTACACCTG ACAAGGTGGC 60 
ACAGTTGGTT CAACTTCATA AAATCAAATA TGTCAGGATT TATGATTCTA ATATACAGGT 120 
TCTGAAGGCC TTTGCAAACA CTGGAATTGA GCTTATGATT GGGGTTCCAA ATTCGGACTT 180 
GCTTTCATTC TCTCAGTTCC AATCTAATGC AGACTCTTGG CTGAAAAACA GCGTGCTTCC 240 
TTACTATCCG GCTACAAAGA TCGCATACAT CACTGTCGGC GCCGAAGTCA CTGAGAGTCC 300 
TAACAATGCA TCTTCATTTG TAGTGCCTGC CATGACCAAT GTGCTTACAG CACTCAAGAA 360 
ACTTGGGCTG CACAAAAAGA TTAAAGTTTC CAGCACCCAT TCCCTTGGGG TTTTGTCGCG 420 
ATCCTTCCCG CCTTCTGCTG GGGCTTTCAA TAGCAGCCAT GCACATTTCC TGAAGCCAAT 480 
GCTAGAATTT CTTGCTGAAA ATCAGTCACC TTTTATGATT GATATATATC CTTATTATGC 540 
CCACCGTGAT TCCCGGAGTA AAGTGTCTTT AGACTATGCC CTGTTTGATG CATCCTCTGA 600 
AGTAATTGAT CCAAACACAG GCTTGCTGTA CACAAACATG TTTGATGCCC AGATTGATGC 660 
TATTTACTTT GCACTGATGG CCTTGGACTT CAGAACAATT AAGGTCATGG TCACTGAGTG 720 
CGGATGGCCG AATTCCG 737 
(2) INFORMATION FOR SEQ ID NO: 8: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 741 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: 
CGGGATCCGG GGTGTGTTAC GGCATGATGG GCGACAATCT ACCACCGGCA AATGAAGTTG 60 
TAAGTCTTTA CAAATCCAAC GACATAATGA GAATGAGAAT CTATAATCCT GATCAAGCTG 120 
CTTTACAAGC ACTGGGAATT TCGGGCATTG AGCTTATTCT TGGGGTGCTC CACCAAGACC 180 
TTCAAGGCCT TGCCACCAAT GCTAGCACTG CTCAACAATG GGTGCAAAGT AACGTGTTGA 240 
ACTTTTGGCC TAGTGTCAAA ATCAAGCACG TGGTAGTTGG CAACGAAATC AATCCTGTGG 300 
GAAGCTCTTC TGAGTTTGCC CAATATGTTC TACCTGCAAT CCAAAACATA TACCAAGCTA 360 
TAAGAGCTCA AGGCCTTCAA GATCTAATCA AGGTTACAAC AGCTATTGAC ATGACCCTGT 420 
TAGGAAACTC CTACCCCCCA TCACAAAGCT ACTTCAGGAC TGATGTGAGA TCATACTTAG 480 
ACCCCATAAT TGGGTACTTG GTATATGCAA ATGCACCTTT ACTAGCCAAT GTGTTGCCTT 540 
ATTTTAGTTA CTCCGATAAC CCGATTGACA TATCACTTTC CTATGCTCTT TTTAACTCAA 600 
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CAAATGTTGT GGTTTGGGAT GGTCAATATG GGTACCAAAA TTTGTTTGAT GCTATGTTGG 
ATGCGGTGCA TGTTGCAATT GATAACACAG GGATTGGTTA TGTGGAGGTT GTTGTATCCG 
AATGGGGTTG GCCGAATTCC G 
(2) INFORMATION FOR SEQ ID NO: 9: 
(i) SEQUENCE CHARACTERISTICS: 
(A) 
(B) 
(C) 
(D) 
LENGTH: 696 base pairs 
TYPE: nucleic acid 
STRANDEDNESS: single 
TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: 
CGGGATCCGG GGTTTGTTAC GGAGGAAAAG GAAACAACCT ACCAAAAATG CAAGCAGTGG 
TGGATTTATA CAAATCAAAC CGAATTGACA AAATCCGTTT ATACCATCCA GACGAAGGAG 
CCCTTCAAGC CCTCAGAGGT TCAAACATAG AGGTGGTCCT CGGTGTCCCT AATGACCAAC 
TTCAATCTCT CATCAATGTT GCAAATGCCA CAAATTGGGT CAACAAGTAC GTGAAAGCAT 
ACTCACAAAA CGTGAAATTC AAGTACATTG CAGTCGGTAA CGAATTCTTT AGCAGGGTCT 
GTACTTCCAG CACTTGAAAA CATTCAGAAC GCAACTTCTG CCGCCAATTT ACAAGGCCAA 
ATGAAGGTGT CAACAGCAAT AGACACCACT TTACTTGGCA ACTCTTACCC ACCAAAAGAT 
GGCGTTTTCA GCAGTAGTGC AAGTTCATAC ATAAGACCAA TTGTAAACTT TTGAGCTAGA 
AATGGAGCTC CACTTCTCGC AAACGTGTAC CCTTACTTCG CCTATGTTAA CGACCAACAA 
AGCATTAGTC TCGACTATGC CTTGTTTACT GAACATGGTA ACAACGAGGC TGGGTACCAA 
AACCTGTTTG ATGCATTGTT GGATTCTCTA TACGCTGCTC TTGAGAAAGT AGGGGCACCC 
AATGTGACGG TTGTTGTGTC TGAAACGGGC TGGCCG 
(2) INFORMATION FOR SEQ ID NO: 10 : 
(i) SEQUENCE CHARACTERISTICS: 
(A) 
(B) 
(C) 
(D) 
LENGTH: 708 base pairs 
TYPE: nucleic acid 
STRANDEDNESS: single 
TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:lO : 
CGGGATCCGG TGTTTGTTAT GGAGTGATTG GTGATAATCT ACCATCAAGG CAAGAAGTTG 
TGGACTTATA TAAAACAAAT GGCATTGGTA GAATGCGTAT ATACTACCCA GATGAAGAAG 
CACTCCAAGC CCTTAGAGGT TCAGGCATTG AGTTGATTAT GGACGTGGCT AAGGAAACCC 
TTCAATCATT GACAGACTCC AATGCTGCTA CAGATTGGGT CAATAAATAT GTTACACCTT 
ACTCGCAAGA CGTCAATTTC AAGTACATCG CTGTTGGAAA TGAAATTCAT CCCAATACCA 
ATGAGGCACA ATATATTCTA TCTGCCATGA CCAACATTCA GAATGCAATT TCATCAGCAA 
ATTTACAAAT TAAGGTGTCA ACAGCTATAG ACTCTACTTT GATTACTAAC TCTTACCCTC 
CCAATGATGG CGTTTTCACT AGCGATGCGG AGCCATACAT AAAACCCATA ATCAACTTCC 
660 
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480 
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TAGTGAGCAA TGGGGCCCCA ATTCTTGCCA ACGTGTACCC TTACTTTGCT TATGCAAATG 
ATCAAAGCAT TCCTCTTGCC TATGCTCTTT TTACCCAACA AGGAAACAAC GACGTTGGGT 
ACCAAAACCT CTTTGATGCT ATGTTGGATT CAATATATGC TGCTTTGGAG AAAGTGGGAG 
CGTCCAATTT GCAGATAGTG GTTTCTGAGT GAGGATGGCC GAATTCCG 
(2) INFORMATION FOR SEQ ID NO: 11 : 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 717 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:ll : 
CGGGATCCGG TGTGTGTTAC GGAGGAAATG GAAACAATCT ACCAACAAAG CAAGCAGTGG 
TGGATCTTTA CAAATCAAAC AGAATAGGCA AAATCCGTTT ATACTATCCA GACGAAGGAG 
TCCTTCAAGC CCTCAGAGGT TCAAACATAG AGGTGATCCT CGGTGTCCCT AATGACCAAC 
TTCATTCTCT CACCAACGCT GGAGCTGCCA CAAATTGGGT CAACAAGTAC GTGAAAGCAT 
ACTCACAAAA CGTGAAATTC AAGTACATTG CAGTTGGTAA CGAAATTCAC CCTGGTGACT 
CTTTAGCAGG GTCTGTACTT CCAGCACTTG AAAACATTCA GAAAGCAATT TCTGCCGCCA 
ATTTACAAGG CCAAATGAAG GTGTCAACAG CAATAGACAC CACTTTACTT GGCAACTCTT 
ACCCACCAAA AGATGGCGTT TTCAGCAGTA GTGCAAGTTC ATACATAAGA CCAATTGTAA 
ACTTTTTAGC AAGAAATGGA GCCCCACTTC TCGCAAACGT GTACCCTTAC TTCGCCTATG 
TTAACAACCA ACAAAGCATT GGTCTTGACT ATGCCTTGTT TACTAAACAT GGTAACAACG 
AGGTTGGGTA CCAAAACCTG TTTGATGCAT TGCTGGATTC CCTATACGCT GCTCTTGAGA 
AAGTAGGGGC ACCAAATGTG AAGGTTGTTG TGTCTGAGTG CGGATGGCCG AATTCCG 
(2) INFORMATION FOR SEQ ID NO: 12 : 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 722 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:l2 : 
CGGAATTCGG CCATCCACTT TCGGATACAA CAACCTCCAC ATAACCAATC TTAGTGTTAT 
CAATGGCTGC ATGTACTGAA TCCAACATAG CATCAAACAA ATTTTGGTAC CCATATTGAC 
CATCCCATAC CACAACATTT GGTGCTGTGA AAAGAGCATA GGGAAGTGAT ATGTCACGGG 
GGTTACCAGT GTAACTAAAA TAAGGGTACA CATTGACTAG TAATGGTGCA TTTGCATATA 
CCAAGTACCC AATTATGGGA TCTATGTATG ATCTCACATC ACCCCTGAAG GAACCTTGCG 
ATGGAGGGAA AGATTTCCTA TTAGGGTCAT GTCAATATAT GTTGAAACCT TGATTTGATC 
TGAAGGCCTT GAGCTCTTAT TGCTTGGTAT ACATTTTGGA TGGCAGGTAG AACATATTGG 
540 
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GCTACCGAAG AAGAGCCTCC AACGGGACTC ACTTCATTTC CAACTGCCAC GTACTTGATT 480 
TTGACACTAG GCCAGAAGTT CTACACGTTT TTTTGCACCC ATTGACGAGA AGTGTCAGGA 540 
TTGGTGGCAA GGCCTTGAAG GTCAGAGTTT GGCACCCCAA GAATGAGTTC AATGCCAGAA 600 
TTTCTAAGTG CTTCTAGAGC AGCTTGATTA GGATCATAGA GTCTCATTCT CTTTATGTTA 660 
TTTGATCTAT AAAGACCTAT AACATCGTTT GCTGACGGTA GATTGTTGCC CAGCATGCCG 720 
TA 722 
What is claimed is: 
1. An isolated DNA molecule selected from the group 
consisting of: SEQ ID NO 1; SEQ ID NO 2; SEQ ID NO 3; 
SEQ ID NO 4; SEQ ID NO 5; SEQ ID NO 6; SEQ ID NO 
7; SEQ ID NO 8; SEQ ID NO 9; SEQ ID NO 10; SEQ ID 
NO 11 and SEQ ID NO 12. 
2. A knockout construct of SEQ ID NO 7. 
3. A vector comprising a knockout construct of SEQ ID 
NO 7. 
4. A seed comprising a knockout construct of SEQ ID NO 
7. 
5. An embryo comprising a knockout construct of SEQ ID 
NO 7. 
6. Aplant comprising a knockout construct of SEQ ID NO 
7. 
7. A method to construct a male-sterile knockout mutant, 
comprising: transforming a plurality of plant cells With a 
knockout construct of SEQ ID NO 7; and inducing the 
plurality of plant cells to groW into a plant; and selecting 
those plants Which are male-sterile. 
15 
25 
8. A plant embryo comprising a vector Which alloWs 
expression at a time other than the late tetrad stage of SEQ 
ID NO 7. 
9. Aplant seed comprising a vector Which alloWs expres 
sion at a time other than the late tetrad stage of SEQ ID NO 
10. A plant comprising a vector Which alloWs expression 
at a time other than the late tetrad stage of SEQ ID NO 7. 
11. Amethod to express [3-1,3-glucanase in a plant Which 
has a callose encasement of microspores, at a time other than 
the late tetrad stage, comprising groWing a plant transformed 
With a vector Which alloWs expression at a time other than 
the late tetrad stage of SEQ ID NO 7. 
12. A method to degrade the callose of seeds, comprising 
expressing SEQ ID NO 7 so as to produce an expression 
product, and alloWing the expression product adequate time 
and conditions to degrade said callose. 
13. A male-sterile soybean seed comprising a knockout 
construct of SEQ ID NO 7. 
* * * * * 
